ValorQ4, 24Q1, 25Q2, 25Q3, 25TTMGastos comerciales, generales y administrativos1.98 B2.2 B2.07 B2.03 B8.28 BInvestigación y desarrollo—————Beneficio operativo1.59 B1.04 B1.41 B1.62 B5.65 BTotal de ingresos no operativos-31 M64 M62 M74 M169 MGastos por intereses, netos de intereses capitalizados45 M49 M74 M63 M231 MIngresos no operativos, una vez deducidos los gastos por intereses195 M15 M-12 M11 M209 MIngresos/gastos extraordinarios-271 M————Beneficio antes de impuestos1.51 B1.05 B1.4 B1.63 B5.59 BParticipación en los beneficios52 M————Impuestos209 M220 M232 M380 M1.04 BParticipación minoritaria46 M47 M53 M64 M210 MOtros ingresos/gastos después de impuestos-213 M-57 M-112 M-40 M-422 MBeneficio neto antes de actividades interrumpidas1.26 B784 M1.11 B1.19 B4.34 BOperaciones suspendidas0————Beneficio neto1.26 B784 M1.11 B1.19 B4.34 BAjuste por dilución—————Dividendos de las acciones preferentes—————Beneficio neto diluido atribuible a los accionistas1.26 B784 M1.11 B1.19 B4.34 BBeneficio básico por acción9.966.288.959.6334.82Beneficio por acción diluido9.96.258.929.5934.66Número medio de acciones ordinarias127.4 M124.9 M124 M123.2 M499.5 MAcciones diluidas128.1 M125.5 M124.4 M123.7 M501.7 MEBITDA1.74 B1.19 B1.59 B1.81 B6.34 BEBIT1.59 B1.04 B1.41 B1.62 B5.65 BCosto de los ingresos87.18 B94.55 B99.61 B102.47 B383.81 BOtros costes de producción—————Amortización y depreciación (flujo de caja)151 M157 M188 M188 M684 M
McKesson Corporation
McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK".
McKesson provides extensive network of infrastructure for the healthcare industry and was an early adopter of technologies, including barcode scanning for distribution, pharmacy robotics, and RFID tags. The company has been named in a federal lawsuit for profiting from the opioid epidemic in the United States.
Throughout the COVID-19 pandemic, McKesson was a key vaccine distributor, serving as the US government's centralized distributor for hundreds of millions of COVID-19 vaccine doses and ancillary supply kits for over a billion doses.